Plantar Fasciitis Now Being Treated With Stem Cells

Plantar fasciitis, a chronic pain condition involving the sole of the foot, is now being treated using regenerative medicine like stem cell therapy, and offering the first form of real relief for many...
Plantar Fasciitis Now Being Treated With Stem Cells
Written by
  • Plantar fasciitis, a chronic pain condition involving the sole of the foot, is now being treated using regenerative medicine like stem cell therapy, and offering the first form of real relief for many sufferers.

    Plantar fasciitis affects millions of Americans, and is a condition in which the plantar fascia – the thick tissue covering the sole of the foot – is inflamed, causing severe pain on the bottom of the foot, and impeding activities such as running and walking.

    The plantar fascia tissue is what connects the heel bone to the toes, thus creating the arch of the foot.

    Traditional treatments for the debilitating injury have offered some relief in recent years through the use of physical therapy, NSAIDS, and steroid injections. However, these types of pain relief develop slowly over time, and are not an effective way to truly treat the problem. Stem cell therapy is going beyond these typical treatments, treating the root cause of the issue, and are often able to alleviate pain more quickly and with longer-lasting results.

    Clinics in Arizona and California are just two examples of offices now offering stem cell injections of adult bone marrow and both fat- and amniotic-derived materials. Board certified pain management doctors at the Arizona Pain Stem Cell Institute, in Phoenix, and TeleHealth, in southern California, are giving patients suffering from the condition a low risk, outpatient alternative to corrective surgery.

    Many other U.S. states now have pain treatment centers offering the plantar fasciitis stem cell therapy, as well.

    Main image courtesy Nevit Dilmen via Wikimedia Commons.

    Get the WebProNews newsletter delivered to your inbox

    Get the free daily newsletter read by decision makers

    Subscribe
    Advertise with Us

    Ready to get started?

    Get our media kit